Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 Infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 4, 2009, Pages 488-492

  Lopardo, Gustavo D ^a,b   Bissio, Emiliano ^a,b   Iannella, María Del C ^a,c   Crespo, Alejandro D ^a,c   Garone, Daniela B ^b   Cassetti, Lidia I ^a,c  

^a Fundacion Centro de Estudios Infectologicos   (Argentina)

^b Hospital Profesor Bernardo Houssay   (Argentina)

^c Helios Salud ^*  (Argentina)

Author keywords

HIV dementia; HIV infection; International HIV dementia scale; Neurocognitive disorders

Indexed keywords

EFAVIRENZ;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; COGNITION; CONTROLLED STUDY; DEMENTIA; EDUCATION; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERNATIONAL HIV DEMENTIA SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; VIRUS LOAD;

ADULT; AGE DISTRIBUTION; AGED; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 74049104782     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b06348     Document Type: Article

References (24)

1. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69: 1789-1799.
2. Hinkin CH, Castellon SA, Atkinson JH, et al. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol. 2001;54(Suppl 1): S44-S52.
3. Chiesi A, Vella S, Dally LG, et al. Epidemiology of AID'S dementia complex in Europe. J Acquir Immune Defic Syndr. 1996;11:39-44.
4. McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol. 1989;26:601-611.
5. Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection. A predictor of dementia, AIDS and death. Neurovirol. 1996;2: 404-410.
6. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: affect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19-S25.
7. Giancola ML, Lorenzini P, Balestra P, et al. Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patientes responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;41:332-337.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
9. McArthur JC. Neurologic manifestations of AIDS. Medicine (Baltimore). 1987;66:407-437.
10. Sacktor NC, Wong M, Nakasujja N, et al. The international dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19: 1367-1374.
11. Berger JR, Brew B. An international screening tool for HIV dementia. AIDS. 2005;19:2165-2166.
12. Davis HF, Skolasky RL Jr, Selnes OA, et al. Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read. 2002;12:29-31, 38.
13. MacArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol. 1989;26:601-611.
14. Miller EN, Selnes OA, MacArthur JC, et al. Neuropsychological performance in HIV-1 infected homosexual men: The Multicenter AIDS Cohortt Study (MACS). Neurology. 1990;40:197-203.
15. Department of Health and Human Services. Panel on Clinical Practices for Treatment of HIV infection convened by the US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents 2008. Available at: http://aidsinfo.nih.gov/contentfiles/ AdultandAdolescentGL.pdf. Accessed December 7, 2008.
16. Sacktor NC. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002;8(Suppl 2):115-121.
17. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56:257-260.
18. Gazzard BG. Efavirenz in the management of HIV infection. Int J Clin Pract. 1999;53:60-64.
19. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 Cohort. Neurology. 2004;63:822-827.
20. Valcour V, Paul R. HIV infection and dementia in older adults. Clin Infect Dis. 2006;42:1449-1454.
21. Marra CM, Lockhart D, Zunt JR, et al. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003;60:1388-1390.
22. Robertson KR, Robertson WT, Ford S, et al. Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr. 2004;36:562-566.
23. Joska JA, Fincham DS, Stein DJ, et al. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. Mar 27, 2009. E-pub ahead of print.
24. De Ronchi D, Faranca I, Berardi D, et al. Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Arch Neurol. 2002;59:812-818.